MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells

by Migneault Martine, Petrie Sarah, Holden Helen, Kapur Arvinder, Belisle Jennifer A, Horibata Sachi, Felder Mildred, Gubbels Jennifer AA, Rancourt Claudine, Connor Joseph P, Patankar Manish S
Published 2010-01-01

Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies

by Goodell Cara AR, Belisle Jennifer A, Gubbels Jennifer AA, Migneault Martine, Rancourt Claudine, Connor Joseph, Kunnimalaiyaan Muthusamy, Kravitz Rachel, Tucker Ward, Zwick Michael, Patankar Manish S
Published 2009-06-01

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

by Rancourt Claudine, Gabius Hans-Joachim, André Sabine, Kapur Arvinder, Petrie Sarah, Jennifer Gubbels AA, Horibata Sachi, Belisle Jennifer A, Connor Joseph, Paulson James C, Patankar Manish S
Published 2010-05-01

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

by Sathyanarayana Bangalore K, Connor Joseph, Bera Tapan K, Ho Mitchell, Migneault Martine, Rancourt Claudine, Onda Masanori, Belisle Jennifer, Gubbels Jennifer AA, Lee Byungkook, Pastan Ira, Patankar Manish S
Published 2006-10-01